Abstract
HIV-infected adults are at an increased risk to lower respiratory tract infections (LRTIs). CD8+CD161++TCRvα7.2+ T cells are an innate-like T cell subset that are thought to play an important role in early defense against pathogens in the respiratory tract. HIV infection leads to irreversible depletion of these cells in peripheral blood, however, its impact on this subset in the human airway is still unclear. Here, we show presence of CD103 expressing CD8+CD161++TCRvα7.2+ T cells in the airway that exhibited a distinct cytokine functional profile compared to their CD103− airway counterparts and those from peripheral blood. These CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells were selectively depleted in untreated HIV-infected adults compared to healthy controls. Their frequency was positively correlated with frequency of airway CD4+ T cells. Furthermore, the frequency of airway CD8+CD161++TCRvα7.2+ T cells was also inversely correlated with HIV plasma viral load, while suppressive antiretroviral therapy (ART) resulted in restoration of airway CD8+CD161++TCRvα7.2+ T cells. Our findings show that CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells are functionally distinct and are preferentially depleted during untreated asymptomatic HIV infection. Depletion of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells, at a major portal of pathogen entry, could partly contribute to the increased propensity for opportunistic LRTIs observed in untreated HIV-infected adults.
Introduction
HIV-infected individuals are at an increased risk to lower respiratory tract infections (LRTIs) (1, ), which account for 75–98% of lung complications in untreated HIV-infected adults worldwide (, ). This susceptibility to LRTIs is largely attributed to HIV-induced disruption of lung immunity, including global alteration in airway immune cell homeostasis (), reduced frequency of respiratory antigen-specific airway CD4+ T cells (, ), as well as, impaired alveolar macrophage function (, ). While these immune cell perturbations partly underlie propensity for LRTIs in HIV-infected individuals, the impact of HIV infection on other important cells involved in early defense (, ), such as airway CD161++TCRvalpha (α)7.2+ T cells, is not well defined.
CD161++TCRvα7.2+ are classical markers for Mucosal-Associated Invariant T (MAIT) cells, which are innate-like T cells present in the liver, blood and mucosal tissues including gut, female genital tract (FGT) and the lung (–). CD161++TCRvα7.2+ T cells have characteristics of innate cells and a degree of sophistication possessed by adaptive lymphocytes. They express a semi-invariant T cell receptor, which recognizes microbial vitamin B2 (riboflavin) metabolites (5-(2-oxoethylideneamino)-6-D-ribitylaminouracil or 5-OP-RU), presented via major histocompatibility complex (MHC) class I-related (MR) 1 molecule (–). CD161++TCRvα7.2+ T cells are present in three main subsets, CD4−CD8− (DN), CD4+, and CD8+ phenotypes (, ). The majority of the CD161++TCRvα7.2+ T cells in peripheral blood are actually of the CD8+ phenotype (). Mature CD161++TCRvα7.2+ T cells display an effector memory phenotype (), are pre-armed with pro-inflammatory and cytolytic effector molecules (, ). This allows them to either lyse infected cells or activate phagocytes very early after infection (, ). Furthermore, CD161++TCRvα7.2+ T cells contribute to regulation of mucosal barrier integrity by secreting IL-22, which promotes epithelial cell proliferation and epithelial tight junction protein expression (, ). These qualities highlight the importance of CD161++TCRvα7.2+ T cells in antimicrobial defense and preservation of mucosal barrier integrity.
CD161++TCRvα7.2+ T cells in the human lower respiratory tract (LRT) are thought to play an important role in defense against respiratory pathogens. Streptococcus pneumoniae and Mycobacterium tuberculosis both induce CD161++TCRvα+ T cell responses through MR1-dependent pathways (, ). In patients with active pulmonary TB, CD161++TCRvα7.2+ T cells are enriched in the lung () and decreased in blood (, 27, ). It has been shown that decrease in MAIT cells frequencies is linked to expression of PD-1 on MAIT cells during HIV and chronic hepatitis C virus (HCV) infection (, ). It was suggested that this expression of PD-1 potentially induces inhibition of MAIT cell proliferation and function due to immune exhaustion (). In an experimental murine M. tuberculosis infection, mice over-expressing CD161++TCRvα7.2+ T cells have lower bacilli load compared to MR1 knockout (KO) mice (). This effect of CD161++TCRvα7.2+ T cells in the lung happens early in infection. In a M. bovis pulmonary infection model, higher bacterial burdens are only observed at day 10 in MR1 KO mice compared to wild type mice (), but not at day 30, suggesting that the impact of CD161++TCRvα7.2+ T cells in controlling bacterial load is much more significant in early than later stages of infection. An intranasal infection of Francisella tularensis live-vaccine strain (LVS) in wild-type and MR1 KO mice, has also established that CD161++TCRvα7.2+ T cells have a direct early antibacterial effect in the lung and a sustained impact on development of effective adaptive mucosal immune response (). Taken together these findings suggest that CD161++TCRvα7.2+ T cells in the mucosal surface of the LRT are poised to provide early control of infection and mediate development of subsequent optimal adaptive immune responses.
HIV infection leads to depletion of peripheral blood CD161++TCRvα+ T cells (, ), which is not reversed by anti-retroviral therapy (ART) (). However, there are conflicting data on the impact of HIV on the functional capacity of CD161++TCRvα7.2+ T cells (, ). CD161++TCRvα7.2+ T cells obtained from untreated HIV-infected individuals were shown to retain their ability to produce IFN-γ and TNF upon stimulation with purified MR1 ligand (). In contrast, following bacterial (E. coli) stimulation, CD161++TCRvα+ T cells from untreated HIV-infected individuals were shown to produce lower levels of IFN-γ, TNF, and IL-17 compared to healthy controls (). Nevertheless, disruption of this important T cell subset likely contributes to increased susceptibility to infection in HIV-infected adults.
Despite important recent advances in CD161++TCRvα7.2+ T cell biology, the phenotype and functional characteristics of human airway CD161++TCRvα7.2+ T cells in health and asymptomatic HIV infection are not well-defined. Accumulating evidence suggests that CD161++TCRvα7.2+ T cells in mucosal sites may differ from those in circulation (, , ). To address this knowledge gap, we examined the frequency, phenotype and functional capacity of human airway CD161++TCRvα7.2+ T cells in healthy controls and asymptomatic HIV-infected adults before and 1 year after initiation of ART.
Materials and Methods
Study Participants
We recruited 80 individuals, classified as HIV-uninfected (n = 39), untreated asymptomatic HIV-infected (n = 41), and HIV-infected on ART (n = 6) at Queen Elizabeth Central Hospital, in Blantyre, Malawi. Participants were recruited from the hospital's Voluntary Counseling and Testing (VCT) clinic and they were all of black African origin. They were asymptomatic adults (≥18 years) with no clinical evidence of active disease, willing to undergo bronchoscopy and BAL for research purposes. Exclusion criteria for the study were current smoker, use of immunosuppressive drugs including ART at recruitment, and known or suspected pregnancy as screened by the study clinical team. Untreated HIV-infected individuals were commenced on ART in line with the “test and treat” strategy soon after undergoing bronchoscopy (within 36 h post HIV diagnosis). Participant demographics including age, sex, CD4 count, and plasma viral load are summarized in Table 1. All enrolled participants gave written informed consent as per protocol approved by College of Medicine Research Ethics Committee (COMREC; protocol P.03/16/1907) and Liverpool School of Tropical Medicine Research Ethics Committee (LSTM REC; protocol 15.054). Due to limitation in cell numbers, not all experiments were done on all samples. Specifically, the frequency of CD161++TCRvα7.2+ T cell data was generated on all 80 samples, the CD103 containing panel was used to generate data on a subset of 40 samples and the cytokine functional profile data was generated on a subset of 22 samples. Furthermore, for this study, we only had access to paired BAL and peripheral blood samples from HIV-uninfected individuals.
Table 1
| HIV-uninfected controls (n = 39) | HIV-infected adults (n = 41) | p-value | |
|---|---|---|---|
| Age (years) | 32 | 32 | 0.4063* |
| Median (range) | (18–52) | (21–58) | |
| Sex (M:F) | 30:9 | 21:20 | 0.0398** |
| CD4 count (cells/μl), | 671 | 319 | <0.0001* |
| Median (IQR) | (523–815) | (213–471) | |
| Plasma viral load (log 10 | N/A | 4.08 | N/A |
| Copies/mL), Median (range) | (2.2–5.8) |
Demographics of study participants.
Unpaired T-test.
Fishers exact test.
IQR, Interquartile range; ART, antiretroviral therapy; N/A, not applicable.
Sample Collection and Experimental Procedures
Bronchoscopy and bronchoalveolar lavage (BAL) were performed on all participants as previously described (). Paired peripheral blood was also obtained from study participants for CD4 count and peripheral blood mononuclear cell (PBMC) isolation using density gradient centrifugation. Cell counts in BAL cells and PBMCs isolated from each sample were performed using a hemocytometer.
Flow Cytometry
Immunophenotyping was performed as previously described (). The antibodies used are described in Supplementary Table 1. BAL cells and PBMCs stimulations were performed using PMA/Ionomycin (Sigma Aldrich, UK) as a stimulant. Briefly, cells were incubated at a concentration of 1 × 106 cells/200 μl in complete medium (200 μl per condition) in the presence of PMA/Ionomycin, BD GolgiPlug (BD Biosciences, UK) and BD GolgiStop (BD Biosciences, UK) for a total of 6 h at 37°C in a 5% CO2 incubator. After stimulation, cells were harvested and washed in PBS. Cells were labeled with the amine reactive dye LIVE/DEAD Fixable Aqua (Molecular Probes, Invitrogen, UK) prior to incubation with antibodies against surface proteins. Cytokines were stained after subsequent fixation/permeabilization with BD Cytofix/Cytoperm (BD Biosciences, UK).
Cytometric Analyses
For all flow cytometric assays, at least 5,000 events in the CD8+ T cell gate were acquired using a LSRFortessa equipped with FACSDIVA software (BD Biosciences). Data were analyzed with FlowJo software (version 10.4.0, Tree Star). For cytokine functional profiles, PESTLE 1.7 and SPICE 5.3 (both NIAID, USA) were used for analysis. The programs PESTLE and SPICE were kindly provided by Mario Roederer, Vaccine Research Center, NIAID, NIH.
Statistical Analysis
Statistical analyses and graphical presentation were performed using GraphPad Prism 5 (GraphPad Software, USA). Non-parametric tests were used to determine significance between groups using the Mann-Whitney two-tailed test (for two groups) or the Wilcoxon matched-pairs two-tailed test (for paired samples) (*p < 0.05; **p < 0.01; ***p < 0.001). Pearson test was used to measured association between parameters.
Results
CD8+CD161++TCRvα7.2+ T Cells Are Present at Similar Frequencies in the Airway Lumen and Systemic Circulation
To determine frequency of CD8+CD161++TCRvα7.2+ T cells from the airway lumen and systemic circulation, we obtained BAL fluid and peripheral blood from healthy HIV-uninfected adults, respectively (Table 1). Using flow cytometric analysis (Figure 1A; Supplementary Figure 1), we found similar frequencies of CD8+CD161++TCRvα7.2+ T cells in airway and peripheral blood samples (Figure 1B). As expected, the majority of CD8+CD161++TCRvα7.2+ T cells from both airways and blood exhibited a memory phenotype (CD45RO+) (94% [75–100] vs. 84% [76–90], p = 0.4867; Figure 1C). CD8+CD161++TCRvα7.2+ T cells were predominantly MR1 5-OP-RU positive (70%) and were the most abundant MR1 5-OP-RU positive population (Supplementary Figures 2, 3). However, due to low event numbers in the airway CD8−CD4−(DN) CD161++TCRvα7.2+ T cell population, we have only focused on the CD8+CD161++TCRvα7.2+ T cell population in this manuscript. These results confirm the presence of mature CD8+CD161++TCRvα7.2+ T cells in the airway of Malawian HIV-uninfected adults.
Figure 1
CD103 Expressing CD8+CD161++TCRvα7.2+ T Cells Are the Predominantly Located in the Airway Lumen Compared to Systemic Circulation
We then further characterized the phenotype of the CD8+CD161++TCRvα7.2+ T cells by measuring CD103, a mucosal retention receptor commonly used to differentiate tissue-resident from infiltrating cells. CD103 is required for retention of cells in tissues as it binds to epithelial cell-expressed E-cadherin (, ). The proportion of CD8+CD161++TCRvα7.2+ T cells expressing CD103 was higher in airway compared to blood (77%[46–49] vs. 2% [0.32–2.6], p < 0.0001; Figures 2A,B). Furthermore, airway CD8+CD161++TCRvα7.2+ T cells expressed higher levels of CD103 compared to airway classical CD8+ T cells (Figure 2C). These results show that airway CD8+CD161++TCRvα7.2+ T cells are predominantly resident cells, but also contains a subset of potentially circulating/non-resident cells.
Figure 2
CD103 Expressing Airway CD8+CD161++TCRvα7.2+ T Cells Possess a Distinct Cytokine Functional Profile
Next, we tested whether CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells were functionally distinct from CD8+CD161++TCRvα7.2+ T cells in peripheral blood (Supplementary Figure 4). The cytokine functional profile was different between airway and blood CD8+CD161++TCRvα+ T cells (Figure 3A). Specifically, a greater proportion of airway CD8+CD161++TCRvα7.2+ T cells were bi-functional compared to those from blood (BAL CD103+ 60% vs. Blood CD103− 30%, p < 0.0001; BAL CD103− 65% vs. Blood CD103− 30%, p = 0.0018). Furthermore, the frequency of IFN-γ & TNF & IL-17A triple-producers, TNF & IL-17A duo-producers, IL-17A single-producers, and IFN-γ single-producers were higher in airway CD103+CD8+CD161++TCRvα7.2+ T cells than peripheral blood CD103−CD8+CD161++TCRvα7.2+ T cells (p < 0.01, p < 0.05, p < 0.01, and p < 0.05, respectively; Figure 3A). On the other hand, the frequency of TNF single-producers were higher in peripheral blood CD103−CD8+CD161++TCRvα7.2+ T cells than in CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells (p < 0.01; Figure 3A).
Figure 3
We then investigated whether there was a functional difference between CD103 expressing CD8+CD161++TCRvα7.2+ T cells compared to non CD103 expressing cells from the airway lumen. The frequency of TNF and IL-17A duo-producers was higher in CD103 expressing than in non CD103 expressing cells (p < 0.01; Figure 3A). Furthermore, the frequency of CD8+CD161++TCRvα7.2+ T cells and classical CD8+ T cells from the airways producing IL-17A was higher in CD103 expressing compared to non CD103 expressing cells (Figure 3B), but this was not the case with IFN-γ or TNF (Supplementary Figure 5). Collectively, the results indicate that CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells are functionally distinct, and that CD103 expression is associated with a propensity for IL-17A-production in airway CD8+ T cells.
Selective Depletion of Airway CD103 Expressing CD8+CD161++TCRvα7.2+ T Cells in Untreated HIV-Infected Adults
HIV is associated with a depletion of peripheral blood CD161++TCRvα7.2+ T cells (, ), we investigated whether asymptomatic HIV infection alters the frequency of airway CD8+CD161++TCRvα7.2+ T cells. The frequency of airway CD8+CD161++TCRvα7.2+ T cells was significantly lower in untreated HIV-infected individuals compared to healthy controls (Figures 4A,B). In a subset of individuals, with paired CD8+ and DN CD161++TCRvα7.2+ T cells, we found no difference in this population between HIV-infected adults compared to healthy controls (Supplementary Figure 3). Specifically, the frequency of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells was lower in untreated HIV-infected adults than in HIV-uninfected controls, but the frequency of non CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells was similar between the two groups (Figure 4C). In contrast, the frequency of total CD8+ T cell was higher in untreated HIV-infected adults than in HIV-uninfected controls (Figure 4D).
Figure 4
Furthermore, there was reduction in the distribution of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells in untreated HIV-infected adults compared to HIV-uninfected adults (52 vs. 78%, p < 0.001; Figure 4E). We also found that the frequency of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells was positively correlated with the frequency of airway CD4+ T cells (p = 0.0273, r = 0.3490; Figure 4F). Collectively, these findings show that depletion of airway CD8+CD161++TCRvα7.2+ T cells in untreated HIV-infected adults targets the CD103 expressing cells.
HIV Viral Burden Is Associated With the Frequency of Airway CD8+CD161++TCRvα7.2+ T Cells
HIV has direct pro-apoptotic impact on diverse cell types (). We therefore determined whether the depletion of airway CD8+CD161++TCRvα7.2+ T cells is associated with HIV viral burden. We measured the association between HIV plasma viral load or peripheral blood CD4 count with frequency of airway CD8+CD161++TCRvα7.2+ T cells in 25 untreated HIV-infected adults with complete data. We found that HIV plasma viral load was inversely correlated with the frequency of airway CD8+CD161++TCRvα7.2+ T cells (Figure 5A). In contrast, the frequency of airway CD8+CD161++TCRvα7.2+ T cells was not directly correlated with peripheral blood CD4 count (Figure 5B).
Figure 5
To ascertain the impact of HIV viral burden on the depletion of airway CD8+CD161++TCRvα7.2+ T cells, we investigated whether suppressive antiretroviral therapy (ART) leads to recovery of airway CD8+CD161++TCRvα7.2+ T cells. We utilized 6 HIV-infected adults to which we had paired baseline CD8+CD161++TCRvα+ T cell data before commencement of ART and 1 year post ART initiation. All individuals had undetectable HIV plasma viral load at 1 year post ART initiation. Representative plots from an HIV-infected participant, before and 1 year following ART initiation (Figure 5C). Despite, having a small sample size, the frequency of airway CD8+CD161++TCRvα7.2+ T cells increased 1 year following initiation of ART (Figure 5D). Collectively, the findings show that HIV could directly or indirectly drive depletion of airway CD8+CD161++TCRvα7.2+ T cells and that ART leads to reconstitution of these cells.
The Cytokine-Functional Profile of Airway CD8+CD161++TCRvα7.2+ T Cells Is Minimally Impacted by HIV Infection
Lastly, we investigated whether HIV infection alters cytokine functional profile of airway CD8+CD161++TCRvα7.2+ T cells. Overall, the cytokine-producing functional profile in airway CD8+CD161++TCRvα7.2+ T cells was not different between untreated HIV-infected adults compared to HIV-uninfected individuals, in both the CD103+ and CD103− cells (Figures 6A,B). However, frequency of CD103+IFN-γ+TNF+IL17A+-poly-functional and CD103−IFN-γ−TNF+IL17A+-bi-functional airway CD8+CD161++TCRvα7.2+ T cells was higher in HIV-infected adults than HIV-uninfected controls (Figures 6A,B). These results show that HIV infection, minimally but differentially, impacts cytokine-functional profile of airway CD8+CD161++TCRvα7.2+ T cell subsets.
Figure 6
Discussion
CD8+CD161++TCRvα7.2+ T cells are part of the innate-like T cell family with important functional relevance in defense against a diverse repertoire of pathogens. There is limited data on the phenotypic and functional characteristics of human airway CD8+CD161++TCRvα7.2+ T cells and how HIV impacts these cells in asymptomatic individuals from high respiratory disease-burdened settings. This study sheds new light on the functional capacity of human airway CD8+CD161++TCRvα7.2+ T cells, their compartmentalized nature, and demonstrates selective depletion of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells in untreated HIV-infected African adults, and reconstitution of airway CD8+CD161++TCRvα7.2+ T cells 1 year following ART initiation.
Consistent with observations that CD8+CD161++TCRvα7.2+ T cells possess different functional characteristics related to their site of origin (, , ), we show that airway CD8+CD161++TCRvα7.2+ T cells are phenotypically and functionally different from those in systemic circulation. Specifically, the majority of the airway CD8+CD161++TCRvα7.2+ T cells express mucosal retention receptor CD103, and are more poly-functional than those from blood. Furthermore, CD103 expressing CD8+CD161++TCRvα7.2+ T cells exhibited propensity for IL-17A production. This is constituent with recent observations from the oral mucosa, showing MAIT cells that exhibit a tissue-resident-activated profile biased toward IL-17 production (). IL-17 plays an important role in mucosal defense as it acts as a bridge between innate and adaptive immunity (45–47) and also induces production of antimicrobial peptides (48). Due to the innate-like function of airway CD8+CD161++TCRvα7.2+ T cells, production of IL-17A and expression of CD103 likely confers these cells readiness and immediate availability to respond quickly to pathogens at a major portal of entry. This is evidenced by observations in animal models that show poor early control of respiratory infections in CD161++TCRvα7.2+ T cell-deficient animals compared to wild type controls (, ).
Certainly, disruption of airway CD8+CD161++TCRvα7.2+ T cell homeostasis could contribute to increased susceptibility to respiratory infections. Consistent with data from non-human primates (49), we show a depletion in airway CD8+CD161++TCRvα7.2+ T cells in untreated HIV-infected adults. Specifically, we show that CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells are selectively depleted in untreated HIV-infected adults. We also observed an inverse correlation between HIV plasma viral load and frequency of airway CD8+CD161++TCRvα7.2+ T cells, supporting a direct or indirect role of HIV in depletion of these cells. CD103 is required for retention of cells in tissues as it binds to epithelial cell-expressed E-cadherin (, ). CD4+ T cells are important for the formation of functional CD103+CD8+ T cells, and we have shown in this study that the frequency of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells was positively correlated with the frequency of airway CD4+ T cells. It has been shown that absence of CD4+ T cells leads to reduced expression of CD103 on CD8+ T cells and subsequent mislocalization of these cells away from airway epithelia (50). Downregulation of CD103 could potentially result in egress of CD8+CD161++TCRvα7.2+ T cells from the airway lumen. It is also plausible that HIV-induced immune activation could lead activation-induced cell death (AICD) (51), immune exhaustion () or to upregulation of intergrins in the lung tissue, resulting in impaired trafficking of CD8+ MAIT cells from the tissue into the airway lumen. This could result in poor replenishment of CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells in the airway lumen.
Consistent with a potential direct or indirect role of HIV on alteration of airway CD8+CD161++TCRvα7.2+ T cell homeostasis, suppressive ART was associated with a reconstitution of airway CD8+CD161++TCRvα7.2+ T cells. CD161++TCRvα7.2+ T cell reconstitution has also been observed in colonic tissue from HIV-infected individuals on ART (52). In contrast to peripheral blood, where CD161++TCRvα+ T cell are not reconstituted by ART (, 52), both colon and respiratory mucosa have diverse microbiota rich with potential CD161++TCRvα7.2+ T cell stimulating commensal microbes (53). Microbial exposure shapes and maintains the CD161++TCRvα7.2+ T cell repertoire (). Germ-free mice lack CD161++TCRvα7.2+ T cell, but acquire them after reconstitution with commensal bacterial strains (, 54). HIV infection disrupts the lung microbiota (55) and this could compromise homeostatic maintenance of airway CD161++TCRvα7.2+ T cells. ART-mediated suppression of viremia could lead to changes in the respiratory microbiota that favor recovery of CD161++TCRvα7.2+ T cell populations in the mucosal compartments.
Interestingly, HIV was not associated with impairment of cytokine-secreting functional potential in airway CD8+CD161++TCRvα7.2+ T cells. This is consistent with data showing retention of IFN-γ and TNF-producing function in peripheral blood-derived CD161++TCRvα7.2+ T cells stimulated with purified MR1 ligand in untreated HIV-infected individuals (). However, it is inconsistent with results obtained following bacterial (E. coli) stimulation of peripheral blood-derived CD161++TCRvα7.2+ T cells, which showed lower levels of IFN-γ, TNF and IL-17 in untreated HIV-infected individuals compared to healthy controls (). It is therefore, plausible, that the overpowering nature of PMA/Ionomycin stimulation could mask the small differences in function between airway CD8+CD161++TCRvα7.2+ T cells from HIV-infected adults and HIV-uninfected controls. On the other hand, PMA/Ionomycin stimulation brings out the full cytokine-secreting functional potential of the airway CD8+CD161++TCRvα7.2+ T cells and by-passes the need for functional antigen-presentation, which could potentially skew results in HIV-infected adults.
While our study provides useful insights into the phenotype and function of airway CD8+CD161++TCRvα7.2+ T cells, we acknowledge some limitations. First, we did not use MR1 tetramers or other surface markers (such as CD26) to identify MAIT cells. However, we have used CD161 and TCRvα7.2, classical MAIT cell markers used by most studies in literature, as well as provided a representative flow cytometry plot showing that over 70% of the CD8+CD161++TCRvα7.2+ T cells stain positive for MR1-5-OP-RU Tetramer (Supplementary Figure 2). Second, we were only able to perform serial bronchoscopy in a subset of individuals due to challenges associated with serial research bronchoscopy. However, the data from the small subset of participants was consistent with the earlier observations that showed an inverse correlation between HIV plasma viral load and frequency of airway CD8+CD161++TCRvα7.2+ T cells. Third, we were not able to further characterize the airway DN CD161++TCRvα7.2+ T cells due to the limitation in event numbers. However, in a subset, we were able to show that HIV infection did not impact this airway DN CD161++TCRvα7.2+ T cell population (Supplementary Figure 3).
In conclusion, we have shown that CD103 expressing airway CD8+CD161++TCRvα7.2+ T cells are functionally distinct from those in systemic circulation, and are preferentially depleted during untreated asymptomatic HIV infection. Disruption of airway CD8+CD161++TCRvα7.2+ T cell homeostasis likely creates a conducive environment for susceptible respiratory pathogens, and could partly contribute to the increased propensity for LRTIs in HIV-infected adults.
Statements
Data availability statement
The datasets generated for this study are available on request to the corresponding author.
Author contributions
KJ, HM, LM, and AM: conception and design. KJ, HM, LM, AM, AH, JP, RK, DM, EC, AK, and RM: analysis and interpretation. KJ, LM, and HM: drafting the manuscript for important intellectual content. KJ, HM, LM, AM, RK, JP, DM, AH, EC, RM, and AK: final approval.
Funding
This work was funded by the Wellcome (UK) through an Intermediate Fellowship number 105831/Z/14/Z awarded to KJ. HM was supported by the MRC (UK) and the Bill and Melinda Gates Foundation through grant numbers MR/P02056/1 and OPP1125279, respectively. The Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW) was supported by a strategic award from the Wellcome.
Acknowledgments
The authors thank all study participants, staff of the Clinical Investigation Unit, MLW, and QECH for their support and co-operation during the study. The MR1-5-OP-RU tetramer and MR1 6FP control were obtained from the NIH Tetramer Core Facility at Emory University.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2019.02003/full#supplementary-material
References
1.
MartinsonNAHoffmannCJChaissonRE. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proc Am Thorac Soc. (2011) 8:288–93. 10.1513/pats.201010-064WR
2.
SegalLNMetheBANolanAHoshinoYRomWNDawsonRet al. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc. (2011) 8:282–7. 10.1513/pats.201006-044WR
3.
MurrayJF. Pulmonary complications of HIV-1 infection among adults living in Sub-Saharan Africa. Int J Tuberc Lung Dis. (2005) 9:826.
4.
BenitoNMorenoAMiroJMTorresA. Pulmonary infections in HIV-infected patients: an update in the 21st century. Eur Respir J. (2012) 39:730–45. 10.1183/09031936.00200210
5.
MwaleAHummelAMvayaLKamng'onaRChimbayoEPhiriJet al. B cell, CD8 (+) T cell and gamma delta T cell lymphocytic alveolitis alters alveolar immune cell homeostasis in HIV-infected Malawian adults. Wellcome Open Res. (2017) 2:105. 10.12688/wellcomeopenres.12869.1
6.
JamboKCBandaDHAfranLKankwatiraAMMalambaRDAllainTJet al. Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria. Am J Respir Crit Care Med. (2014) 190:938–47. 10.1164/rccm.201405-0864OC
7.
JamboKCSepakoEFullertonDGMzinzaDGlennieSWrightAKet al. Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Thorax. (2011) 66:375–82. 10.1136/thx.2010.153825
8.
JamboKCBandaDHKankwatiraAMSukumarNAllainTJHeydermanRSet al. Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function. Mucosal Immunol 2014. 10.1038/mi.2013.127
9.
Van DykenSJNussbaumJCLeeJMolofskyABLiangHEPollackJLet al. A tissue checkpoint regulates type 2 immunity. Nat Immunol. (2016) 17:1381–7. 10.1038/ni.3582
10.
MeierovicsAYankelevichWJCowleySC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA. (2013) 110:E3119–28. 10.1073/pnas.1302799110
11.
BillerbeckEKangYHWalkerLLockstoneHGrafmuellerSFlemingVet al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci USA. (2010) 107:3006–11. 10.1073/pnas.0914839107
12.
GibbsALeeansyahEIntroiniAPaquin-ProulxDHasselrotKAnderssonEet al. MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation. Mucosal Immunol. (2017) 10:35–45. 10.1038/mi.2016.30
13.
JiangJChenXAnHYangBZhangFChengX. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. (2016) 6:32320. 10.1038/srep32320
14.
SharmaPKWongEBNapierRJBishaiWRNdung'uTKasprowiczVOet al. High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells. Immunology. (2015) 145:443–53. 10.1111/imm.12461
15.
ChenZWangHD'SouzaCSunSKostenkoLEckleSBet al. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol. (2017) 10:58–68. 10.1038/mi.2016.39
16.
GoldMCCerriSSmyk-PearsonSCanslerMEVogtTMDelepineJet al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. (2010) 8:e1000407. 10.1371/journal.pbio.1000407
17.
Le BourhisLMartinEPeguilletIGuihotAFrouxNCoreMet al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol. (2010) 11:701–8. 10.1038/ni.1890
18.
DiasJBoulouisCGorinJBvan den BiggelaarRLalKGGibbsAet al. The CD4(-)CD8(-) MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8(+) MAIT cell pool. Proc Natl Acad Sci USA. (2018) 115:E11513–22. 10.1073/pnas.1812273115
19.
YongYKTanHYSaeidiARosmawatiMAtiyaNAnsariAWet al. Decrease of CD69 levels on TCR Valpha7.2(+)CD4(+) innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients. Innate Immun. (2017) 23:459–67. 10.1177/1753425917714854
20.
MartinETreinerEDubanLGuerriLLaudeHTolyCet al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. (2009) 7:e54. 10.1371/journal.pbio.1000054
21.
LeeansyahELohLNixonDFSandbergJK. Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nat Commun. (2014) 5:3143. 10.1038/ncomms4143
22.
GoldMCNapierRJLewinsohnDM. MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev. (2015) 264:154–66. 10.1111/imr.12271
23.
UssherJEKlenermanPWillbergCB. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol. (2014) 5:450. 10.3389/fimmu.2014.00450
24.
SonnenbergGFFouserLAArtisD. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. (2011) 12:383–90. 10.1038/ni.2025
25.
KimCJNazliARojasOLChegeDAlidinaZHuibnerSet al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. (2012) 5:670–80. 10.1038/mi.2012.72
26.
KuriokaAvan WilgenburgBJavanRRHoyleRvan TonderAJHarroldCLet al. Diverse Streptococcus pneumoniae strains drive a mucosal-associated invariant T-cell response through major histocompatibility complex class I-related molecule-dependent and cytokine-driven pathways. J Infect Dis. (2018) 217:988–99. 10.1093/infdis/jix647
27.
KwonYSChoYNKimMJJinHMJungHJKangJHet al. Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity. Tuberculosis. (2015) 95:267–74. 10.1016/j.tube.2015.03.004
28.
JiangJWangXAnHYangBCaoZLiuYet al. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis. Am J Respir Crit Care Med. (2014) 190:329–39. 10.1164/rccm.201401-0106OC
29.
BarathanMMohamedRVadiveluJChangLYSaeidiAYongYKet al. Peripheral loss of CD8(+) CD161(++) TCRValpha7.2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients. Eur J Clin Invest. (2016) 46:170–80. 10.1111/eci.12581
30.
SaeidiATien TienVLAl-BatranRAl-DarrajiHATanHYYongYKet al. Attrition of TCR Valpha7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression. PLoS ONE. (2015) 10:e0124659. 10.1371/journal.pone.0124659
31.
SaeidiAEllegardRYongYKTanHYVeluVUssherJEet al. Functional role of mucosal-associated invariant T cells in HIV infection. J Leukoc Biol. (2016) 100:305–14. 10.1189/jlb.4RU0216-084R
32.
SakalaIGKjer-NielsenLEickhoffCSWangXBlazevicALiuLet al. Functional heterogeneity and antimycobacterial effects of mouse mucosal-associated invariant T cells specific for riboflavin metabolites. J Immunol. (2015) 195:587–601. 10.4049/jimmunol.1402545
33.
ChuaWJTruscottSMEickhoffCSBlazevicAHoftDFHansenTH. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun. (2012) 80:3256–67. 10.1128/IAI.00279-12
34.
LeeansyahEGaneshAQuigleyMFSonnerborgAAnderssonJHuntPWet al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. (2013) 121:1124–35. 10.1182/blood-2012-07-445429
35.
WongEBAkilimaliNAGovenderPSullivanZACosgroveCPillayMet al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS ONE. (2013) 8:e83474. 10.1371/journal.pone.0083474
36.
CosgroveCUssherJERauchAGartnerKKuriokaAHuhnMHet al. Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood. (2013) 121:951–61. 10.1182/blood-2012-06-436436
37.
FernandezCSAmarasenaTKelleherADRossjohnJMcCluskeyJGodfreyDIet al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. (2015) 93:177–88. 10.1038/icb.2014.91
38.
LeeansyahESvardJDiasJBuggertMNystromJQuigleyMFet al. Arming of MAIT cell cytolytic antimicrobial activity is induced by IL-7 and defective in HIV-1 infection. PLoS Pathog. (2015) 11:e1005072. 10.1371/journal.ppat.1005072
39.
BoothJSSalerno-GoncalvesRBlanchardTGPatilSAKaderHASaftaAMet al. Mucosal-associated invariant T cells in the human gastric mucosa and blood: role in helicobacter pylori infection. Front Immunol. (2015) 6:466. 10.3389/fimmu.2015.00466
40.
CheukSSchlumsHGallais SerezalIMartiniEChiangSCMarquardtNet al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity. (2017) 46:287–300. 10.1016/j.immuni.2017.01.009
41.
CepekKLShawSKParkerCMRussellGJMorrowJSRimmDLet al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature. (1994) 372:190–3. 10.1038/372190a0
42.
TophamDJReillyEC. Tissue-resident memory CD8(+) T cells: from phenotype to function. Front Immunol. (2018) 9:515. 10.3389/fimmu.2018.00515
43.
CumminsNWBadleyAD. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis. (2010) 1:e99. 10.1038/cddis.2010.77
44.
SobkowiakMJDavanianHHeymannRGibbsAEmgardJDiasJet al. Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17. Eur J Immunol. (2019) 49:133–43. 10.1002/eji.201847759
45.
GuglaniLKhaderSA. Th17 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS. (2010) 5:120–7. 10.1097/COH.0b013e328335c2f6
46.
ChenKEddensTTrevejo-NunezGWayEEElsegeinyWRicksDMet al. IL-17 Receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against K. pneumoniae. Cell Host Microbe. (2016) 20:596–605. 10.1016/j.chom.2016.10.003
47.
IshigameHKakutaSNagaiTKadokiMNambuAKomiyamaYet al. Differential roles of interleukin-17A and−17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. (2009) 30:108–19. 10.1016/j.immuni.2008.11.009
48.
ArcherNKAdappaNDPalmerJNCohenNAHarroJMLeeSKet al. Interleukin-17A (IL-17A) and IL-17F are critical for antimicrobial peptide production and clearance of staphylococcus aureus nasal colonization. Infect Immun. (2016) 84:3575–83. 10.1128/IAI.00596-16
49.
VintonCWuFRossjohnJMatsudaKMcCluskeyJHirschVet al. Mucosa-associated invariant T cells are systemically depleted in simian immunodeficiency virus-infected rhesus macaques. J Virol. (2016) 90:4520–9. 10.1128/JVI.02876-15
50.
LaidlawBJZhangNMarshallHDStaronMMGuanTHuYet al. CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection. Immunity. (2014) 41:633–45. 10.1016/j.immuni.2014.09.007
51.
PopescuIDrummondMBGamaLCoonTMerloCAWiseRAet al. Activation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2014) 190:744–55. 10.1164/rccm.201407-1226OC
52.
GreatheadLMetcalfRGazzardBGotchFSteelAKelleherP. CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation. AIDS. (2014) 28:1690–2. 10.1097/QAD.0000000000000351
53.
RingelYMaharshakNRingel-KulkaTWolberEASartorRBCarrollIM. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes. (2015) 6:173–81. 10.1080/19490976.2015.1044711
54.
TreinerEDubanLBahramSRadosavljevicMWannerVTilloyFet al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. (2003) 422:164–9. 10.1038/nature01433
55.
TwiggHLIIIWeinstockGMKnoxKS. Lung microbiome in human immunodeficiency virus infection. Transl Res. (2017) 179:97–107. 10.1016/j.trsl.2016.07.008
Summary
Keywords
airway, HIV, CD103, CD8 T cell, adult
Citation
Mvaya L, Mwale A, Hummel A, Phiri J, Kamng'ona R, Mzinza D, Chimbayo E, Malamba R, Kankwatira A, Mwandumba HC and Jambo KC (2019) Airway CD8+CD161++TCRvα7.2+ T Cell Depletion During Untreated HIV Infection Targets CD103 Expressing Cells. Front. Immunol. 10:2003. doi: 10.3389/fimmu.2019.02003
Received
17 May 2019
Accepted
07 August 2019
Published
21 August 2019
Volume
10 - 2019
Edited by
Mats Bemark, University of Gothenburg, Sweden
Reviewed by
Esaki M. Shankar, Central University of Tamil Nadu, India; Edwin Leeansyah, Karolinska Institute (KI), Sweden
Updates
Copyright
© 2019 Mvaya, Mwale, Hummel, Phiri, Kamng'ona, Mzinza, Chimbayo, Malamba, Kankwatira, Mwandumba and Jambo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kondwani C. Jambo kondwani.jambo@lstmed.ac.uk; kjambo@mlw.mw
This article was submitted to Mucosal Immunity, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.